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presented anti-Zika antibodies at the time of delivery. A total of
7 (6.8%) newborns were diagnosed with microcephaly, while 96
(93.2%) were classiﬁed as newborns without microcephaly.
Methods & Materials: In June 2017, we began a prospective
follow-up of these infants without microcephaly exposed to Zika
Virus in utero by evaluating neurodevelopment delays, performing
neurological examinations and applying the Bayley Scales of Infant
Development III (BSID-III), Mental Development Index (MDI) and
Bayley-III cognitive and language scales. Auditory evaluationswere
performed by Otoacustic emissions (OAE) and Brainstem Auditory
Evoked Potential (BAEP).
Results: To date we have evaluated 18 infants, mean age 1.7
years. Of these, 55.6% aremale and61%weredeliveredbyC-section.
Anti-Zika IgG serology was positive in 75% and three (16.6%) pre-
sented positivity for Zika by PCR on urine samples within 24h of
birth. Based on head circumference (HC) at time of birth, all were
classiﬁed as normal by the Intergrowth scale and currently fall
within normalHCpercentiles. Cognitive delaywas identiﬁed in ﬁve
(33%) infants, language delay in four (26.6%) andmotor delay in two
(13.3%).
Conclusion:Our preliminary results indicate that in utero expo-
sure to Zika virus could be associated with neurodevelopmental
delay, even in children born without microcephaly at birth. Cur-
rently, only microcephalic infants are referred to specialized care,
while normocephalic children are maintained in primary health
care. We believe that all newborns exposed to Zika in utero should
be referred to specialized centers for the early detection of neu-
rodevelopmental delays and timely intervention.
https://doi.org/10.1016/j.ijid.2018.04.3533
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Background: An unprecedented and concurrent outbreak of
Dengue (DENV), Chikungunya (CHIKV) and Zika (ZIKV) virus hap-
pened in Brazil in 2015. Approximately 18.372 cases of an acute
exanthematous illness were notiﬁed in Salvador, Bahia and several
cases of Guillain-Barré Syndrome (GBS) raised.
Methods & Materials: We started a hospital surveillance for
GBS and other neurological syndromes in two general hospitals in
Salvador, northeastern Brazil.
Results: Twenty-seven cases were included, of which 18 (66%)
were female. The mean age was 40 years and 26 (93%) of them had
acute symptoms suggestive of arbovirus infection before the onset
ofneurological symptoms. Themain symptomswere skin rash, pru-
ritus, myalgia, and fever. The median time between onset of acute
symptoms and neurological symptoms was 10.5 days. Seventeen
cases (63%) were classiﬁed as GBS, 3 (11%) as acute encephalitis,
2 (7%) as opsoclonus-myoclonus ataxia syndrome (OMS), 2 (7%)
as myelitis, 1(4%) as Carpal tunnel syndrome and 1 (4%) as acute
disseminated encephalomyelitis (ADEM). GBS cases presented in
a variety of clinical spectrum, with 8 (47%) as acute ataxic neu-
ropathy, 5 (29%) as classic GBS, 2 (11%) as bifacial weakness with
paraesthesias, 1 (5%) as paraparetic GBS and 1 (5%) as classic
Miller-Fischer syndrome. Twelve (44%) patients were admitted to
semi-intensive or intensive care units and none died. The arbovirus
diagnosis was established in 21(77.8%) of the cases. Serological
evaluation by ELISA singly detected IgM-speciﬁc DENV antibodies
in 3 cases (2 SGB and 1 Myelitis), IgM-speciﬁc CHIKV antibodies
in 4 cases (3 SGB and 1 myelitis) and IgM-speciﬁc ZIKV antibod-
ies in 3 cases (SGB). Six cases had both anti-ZIKV and anti-DENV
(2 SGB, 2 encephalitis, 1 ADEM, 1 OMS) with a presumptive ZIKV
diagnosis. One case of OMShad a coinfection by CHIKV andDENV-4
established by RT-PCR.
Conclusion: Herein, we describe 28 cases of GBS and other
neurological syndromes associated with arboviruses. Besides GBS,
we also identiﬁed cases of encephalitis, ADEM and OMS, a rare
syndrome characterized by chaotic eyes movement and ataxia.
Thereafter, clinicians and health care providers should be aware
of the potential severe neurological complications associated with
arbovirus infection in epidemic areas.
https://doi.org/10.1016/j.ijid.2018.04.3534
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Background: Zika virus disease emerged in Latin America in
early 2015, which had serious implications for population health.
In 2016, the World Health Organization declared a cluster of neu-
rological disorders and neonatal malformations associated with
Zika cases a Public Health Emergency of International Concern.
2017 incidence has declined, and future disease incidence in Latin
America remains uncertain due to gaps in our understanding of
the natural history of infection, considerable variation in surveil-
lance and a lack of a comprehensive collation of available data from
affected countries.
Methods & Materials: This analysis combines publically avail-
able data on Zika virus incidence across most Latin American
countries and a spatio-temporal dynamic transmission model for
Zika virus infection to determine key transmission parameters and
likely future incidence in 87 cities. Seasonality was determined
by spatio-temporal estimates of Aedes aegypti vector capacity.
Country and state-level data are used to infer key model parame-
ters usingMonte-Carlomethods, differentmovementmodelswere
testedagainst thedata and thebest-ﬁttingparameter combinations
were used to estimate incidence within each city.
Results: We predict that the highest incidence in 2018 will be
observed in Colombia and some Brazilian States (Parana, Sao Paulo,
Rio de Janiero and Minas Gerias), but the estimated number of
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infections will be no more than a few hundred and the incidence
risk ratio will be below 0.05. There was limited transmission in
2015, but formost cities 2016and2017provideda sufﬁcient oppor-
tunity for ZIKV transmission and populations have been depleted
of susceptible individuals.
Conclusion: The ﬁndings suggest that much of the ZIKV-
associatedmorbidity will be in neonates and children that are born
up to the end of 2017. The ﬁndings present a challenge to planned
ZIKV-speciﬁc interventions such as phase III vaccine trials, as we
predict substantially lower numbers of infections in 2018.
https://doi.org/10.1016/j.ijid.2018.04.3535
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Background: Arboviruses are transmitted by arthropods. The
most common in Brazil, are: Yellow Fever, Dengue and recently
Chikungunya and Zika. Zika has emerged associated with cases
of fever, arthralgia, Guillain-Barré syndrome and congenital mal-
formation. Beyond, cases of microcephaly in newborn were
associations with ZIKV infections. Further studies are needed to
conﬁrm this association.
Methods & Materials: From May 2016 to date, 757 pregnant
women are being followed up in a cohort study. Blood, saliva and
urine were collected from pregnant women and newborns. In the
ﬁrst sample of the mothers the ELISA was performed to detect
IgG immunoglobulins anti ZIKV, CHIKV and DENV. The ELISA was
performed in 728 (96.2%) of this women.
Results: ZIKV ELISAwas performed in 350 pregnant women: 15
(4.2%) positive, 334 (95.4%) negative and one (0.3%) undetermined.
Among ZIKV negative cases, 48 (14.4%) were ZIKV positive by RT-
qPCR. Of the positive cases, 3 (0.9%) were also ZIKV positive by
RT-qPCR. CHIKV ELISA was performed in 709 pregnant women, 63
(8.9%) positive,629 (88.7%) negative and 17 (2.4%) undetermined.
DENV ELISA was performed in 253 pregnant women, 55 (21.7%)
positive,195 (77.1%) negative and 2 (0.8%) undetermined. The diag-
nosis for three arboviruses were performed in 168 women: Four
(2.4%)were ZIKVpositive, 4 (2.4%) CHIVK, 31 (18.5%)DENV, 3 (1.8%)
ZIKV and DENV and one (0.6%) CHIKV and DENV. Nine (5.4%) of
theses mothers were ZIKV positive by RT-qPCR. Two (1.2%) moth-
ers had children ZIKV positive by RT-qPCR. Three (1.8%) newborns
with microcephaly were detected; one positive for DENV and the
other two were negative for any Arboviruses studied.
Conclusion: The individually diagnosis, detected high occur-
rence of ZIKV (14.4%) and DENV (21.7%) and lower occurrence of
CHIKV 63 (8.9%). Cases of co-infection can be detected, at lower
levels. The number of patients with complete diagnosis is small,
yet. But IgG ELISAswill be performed on remainingmothers and all
newborns and IgM ELISA will be performed for all participants.
Financial support: FAPESP (2016 / 08578-0)
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Given the complex nature of diagnostic practices for infectious
diseases, the one unifying characteristic of the agents investigated
is their possession of a genome. While many molecular diagnostic
tests investigate parts of the genome, whole-genome sequencing
(WGS) has emerged as a cost-effective and convenient approach
for answering the varied microbiological questions that arise. In
that regard, four essential tasks are addressed: species identiﬁca-
tion, phenotypic characterization, e.g., antimicrobial resistance and
virulence, evolutionary traits and pathogen tracking.
Some of the beneﬁts already available include, in addition to the
ability to fully characterize prospective and retrospective isolates,
the ability to be applied directly to clinical samples for simulta-
neous identiﬁcation and predicting antimicrobial susceptibilities
(even in culture-negative cases); identiﬁcation in polymicrobial
samples; generating regional phylogenomic sublineages; corre-
lation of genomic features with strains of clinical importance;
tracking of multidrug resistant organisms in hospitals and com-
munities. These beneﬁts, while largely seen in reports from North
America and Europe, are also being observed in Latin America and
theCaribbean. Further,WGSallows for estimationofmutation rates
among isolates, as well as assessment of the rates and breadth of
horizontal gene ﬂow within and between species, the evolution of
new virulence traits, and the role of host genetics in host-pathogen
interactions, all with the view to develop novel therapeutic inter-
ventions.
The main directions of WGS applications include diagnosis and
control of local and regional infectious diseases; detection of mul-
tidrug resistance (MDR) and virulence characteristics; surveillance
of pathogen evolution and transmission dynamics; development
of new (portable) diagnostic tests and assays for use in clinics and
outpatient facilities; and discovery of novel antimicrobial drugs
and therapeutics and assessment of their prevention and control.
Given thatpathogensoccur in complexmicrobial communities, fur-
ther elaborations to explore the pathobiome using metagenomics
andhigh-throughput sequencingwill assistwith theunderstanding
of the forces supporting population structure, including pathogen
plasticity.
https://doi.org/10.1016/j.ijid.2018.04.3537
